Blog Post Research & Development Biotech What a Recent CRISPR Breakthrough Means for Therapeutics Companies A paper published this month proving that the use of RNA transposons can improve the CRISPR process has excited the ...
Blog Post Life Sciences Biotech Breaking Down the Keys to Decentralized Clinical Trials Clinical trials have long been viewed as complicated and high-volume endeavors, involving the widespread recruitment of patients, supply chain planning ...
Blog Post Life Sciences Biotech 3 Key Trends Disrupting R&D Strategy The most innovative organizations have demonstrated their success stems from creative strategy paired with iterative and efficient execution. It’s all ...
Blog Post Life Sciences Biotech Genetic Data’s Privacy Conundrum Underlying all of the widespread uses of genetic testing—diagnostic testing, carrier testing, prenatal testing, consumer-oriented genetic testing, etc.—few issues loom ...
Blog Post Life Sciences Pharma 7 Improvements in Clinical Supply Chain Management Your CFO Will Love “The right dose of the right medicine delivered to the right patient at the right time…and at the right cost”. ...
Blog Post Life Sciences Pharma Applications of AI in Drug Development Over the last two years, discussions about the applications of AI have broken through the mainstream and reached a level ...
Blog Post Life Sciences Pharma Innovation in R&D Processes and Systems The meticulous art of R&D demands extensive collaboration, mastery of technical skills, and scientific acumen. In and of itself, the ...
Blog Post Life Sciences Biotech Transparency in Clinical Study Reporting For pharmaceutical and biotechnology companies focusing on research and development, prioritizing data transparency and clinical study reporting (CSR) is a ...
Blog Post Life Sciences Pharma How Will New Pfizer CEO Albert Bourla Impact R&D Strategy? In recent news, Pfizer Chief Executive Officer Ian Read stated he will step down at the end of 2018 after ...
